Dendritic cell vaccines extend <scp>CAR</scp> T‐cell persistence and improve the efficacy of <scp>CD19 CAR</scp> T‐cell therapy in refractory or relapsed adult <scp>B‐ALL</scp> patients

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27349

Keywords:

Abstract:

Source: